Mizuho Securities USA’s Clarus Therapeutics Holdings, Inc. Warrants CRXTW Stock Holding History

Mizuho Securities USA’s Portfolio CRXTW Stock Details CRXTW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-100,000	Closed	-$1K	–	274
2022 Q3	$1K	Hold	100,000	–	–	﹤0.01%	223
2022 Q2	$5K	Buy	100,000 +75,000	+300%	+$7.38K	﹤0.01%	122
2022 Q1	$4K	Buy	+25,000	New	+$4.54K	﹤0.01%	196

Mizuho Securities USA's CRXTW Position: Q4 2022 in Review

Mizuho Securities USA sold out of Clarus Therapeutics Holdings, Inc. Warrants (CRXTW) in Q4 2022, closing a stake of 100,000 shares — an estimated $1K sold.

Mizuho Securities USA first reported a position in CRXTW in Q1 2022 and held it in 3 quarters. The position peaked at $5K in Q2 2022. 0 funds tracked by Wall St. Rank hold CRXTW as of Q4 2022.

Mizuho Securities USA reported no remaining Clarus Therapeutics Holdings, Inc. Warrants position as of Q4 2022 after selling out during the quarter.
Mizuho Securities USA sold 100,000 Clarus Therapeutics Holdings, Inc. Warrants shares in Q4 2022, an estimated $1K.
Mizuho Securities USA first reported a position in Clarus Therapeutics Holdings, Inc. Warrants in Q1 2022 and held it in 3 quarters.
Mizuho Securities USA's Clarus Therapeutics Holdings, Inc. Warrants position peaked at $5K in Q2 2022.
0 funds tracked by Wall St. Rank held Clarus Therapeutics Holdings, Inc. Warrants as of Q4 2022.

Based on Mizuho Securities USA's 13F filing for Q4 2022, filed 3 Feb 2023.